United States

Xiangxue Pharmaceutical Co Ltd (300147.SZ)

300147.SZ on Shenzhen Stock Exchange

21 Oct 2016
Change (% chg)

¥-0.09 (-0.63%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 300147.SZ


Xiangxue Pharmaceutical Co., Ltd. is principally engaged in the production and distribution of Chinese patent medicine. The Company provides tablets, capsules, granules, oral liquids and aerosols, among others. The Company's major products include antiviral oral liquids and indigowoad root granules. The Company distributes its... (more)


Beta: 0.85
Market Cap(Mil.): ¥9,419.42
Shares Outstanding(Mil.): 661.48
Dividend: 0.12
Yield (%): 0.84


  300147.SZ Industry Sector
P/E (TTM): 74.09 36.28 36.15
EPS (TTM): 0.19 -- --
ROI: 4.23 14.43 13.90
ROE: 4.10 15.21 14.83

BRIEF-Xiangxue Pharmaceutical to set up life insurance JV

* Says it plans to invest 160 million yuan to set up life insurance firm with registered capital at 1.0 billion yuan

Oct 21 2016

BRIEF-Xiangxue Pharma signs framework agreement on Chinese medicine related projects

* Says it signs framework agreement on chinese medicine related projects with investment of 750 million yuan ($111.35 million)

Oct 19 2016

BRIEF-Xiangxue Pharmaceutical sees 2016 Q1~Q3 net profit to decrease by 35 pct to 50 pct

* sees 2016 Q1~Q3 net profit to decrease by 35 percent to 50 percent, compared to net profit of Q1~Q3 in 2015(145.1 million yuan)

Oct 14 2016

BRIEF-Xiangxue Pharmaceutical issues 2016 1st tranche super short-term financing notes worth 750 mln yuan

* Says it issues 2016 first tranche super short-term financing notes worth 750 mln yuan, with a term of 270 days and coupon rate of 3.39 percent

Aug 29 2016

BRIEF-Xiangxue Pharmaceutical unit to set up Chinese medicine hospital management unit

* Says its 70-percent-owned unit, Haozhou-based pharmaceutical company, plans to set up wholly owned unit in Haozhou

Aug 14 2016

BRIEF-Xiangxue Pharmaceutical to hold 60 percent stake in biotechnology co

* Says it will hold 60 percent stake in Guangdong-based biotechnology co via stake acquisition and capital injection

Jun 21 2016

BRIEF-Xiangxue Pharmaceutical's CFO Chen Wenjin resigns

* Says the co's CFO Chen Wenjin resigned from the position of CFO

Jun 21 2016

BRIEF-Xiangxue Pharmaceutical to pay 2015 dividend on June 3

* Says it will pay cash dividend of 0.12 yuan per share (before tax) for 2015 to shareholders of A shares of record on June 2

May 30 2016

BRIEF-Xiangxue Pharma plans medical investment fund, unit to invest in Chinese medicine project

* Says plans to set up medical and healthcare investment fund of size 1 billion yuan ($154.40 million) with partners

May 03 2016

Earnings vs. Estimates